An interventional study of Attention to Context (ATC) training and Affective Cognitive Control (ACC) training in Antisocial Behavior, sponsored by The Mind Research Network. Recruiting at 1 site in United States. Open to male participants aged 18 Years to 55 Years. Per ClinicalTrials.gov, last updated 2026-08-17.
Sponsored by The Mind Research Network · Not applicable, Interventional, and Treatment
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 26 studies in Antisocial Personality Disorder with a site in United States — 4 open to participants now, 6 under way, none of them phase 3. Antisocial Personality Disorder · United States.
Among the 26 studies in Antisocial Personality Disorder with a site in United States, this one is the 5th largest by planned enrollment of the 18 interventional ones that give a count, is the only one that started in 2025, is one of 13 with no phase, and was the 25th registered.
67 studies on the registry are indexed under Antisocial Personality Disorder; 10 are open to participants now.
Browse Antisocial Personality Disorder studies →4 of the 26 studies in Antisocial Personality Disorder with a site in United States are open now. Recruiting first, the newest first:
University of Colorado, Denver · Sites in United States
Ages 18–60
Boston Children's Hospital · Sites in United States
Ages 18–45 · Women only
University of Minnesota · Sites in United States
Ages 18–75 · Healthy volunteers
A study can be open while its sites in United States have not opened yet or have stopped. Only those recruiting at a site in United States →
Of the 9 Antisocial Personality Disorder studies recruiting now, none set no upper age limit and 8 stop at 75 or younger; 1 takes children under 18; 1 takes healthy volunteers.
This study: 18 Years to 55 Years · male · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
26 studies; the count open now beside each. This study's row is marked.
A study in two phases is counted once above. Listed by phase, each with its combined phases: Phase 1 1 · Phase 2 3 · Phase 3 1 · Phase 4 1
First in 1991; this study’s year is marked. 1 started in 2025.
By drug class, each counting the studies that test any of its medicines:
This study's planned enrollment of 288 is above the median of 140 across 43 interventional studies indexed under Antisocial Personality Disorder.
Median enrollment 188 across the 18 interventional studies, 267 across the 8 observational. Of the 18 that completed or were terminated, 7 (39%) have results posted.
This tab as a report to print or save as PDF → With an account.
1 of 26 have an industry lead sponsor. The 10 most frequent:
The Mind Research Network is the lead sponsor of 18 studies on the registry; 5 are open to participants now.
Of its 6 completed or terminated interventional studies of FDA-regulated products, 4 (67%) have results posted.
The Mind Research Network has 1 study filed under Antisocial Personality Disorder — fewer than ten, so there is no comparison to draw.
1 of the studies in Antisocial Personality Disorder with a site in United States that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT06056635Boston Children's HospitalA Prospective Study on the Role of Karl Storz Curved and Straight Fetoscopes (11508AAK and 11506AAK) for Fetoscopic Intrauterine Procedures | 2026-12-01 |
Add it to your calendar (.ics) → With an account.
Among the 26 studies in Antisocial Personality Disorder with a site in United States, from their registry updates:
This tab as a report to print or save as PDF → With an account.
The goal of this clinical trial is to investigate the effect of two types of cognitive remediation training on real-world behavioral outcomes including substance use, institutional adjustment, and recidivism following release from prison. Each training type is designed to target one of two subtypes of antisocial criminal offenders, who are characterized by either: 1) Attention to context-based deficits, or 2) Affective cognitive control-based deficits.
The main questions it aims to answer are:
Does matching deficit type with targeted cognitive training improve outcomes (relative to mismatched training)? What are the functional brain mechanisms that underlie treatment change?
Participants will:
Be assigned to cognitive training that either does or does not match their deficit type.
Complete six one-hour sessions of cognitive skills training. Complete pre and post-training behavioral tasks assessing self-regulation deficits.
Complete structural MRI scans and functional MRI scans assessing cognitive control.
Complete post-treatment follow-up assessments evaluating self-regulation, adjustment, and stressful life events, substance use and recidivism.
Prior research has identified two subtypes of antisocial offenders, typified by distinct dysfunctional cognitive emotion interactions undermining self-regulation. One subtype is characterized by an attention-based abnormality, which impairs adaptive processing of contextual information, tangential to one's primary focus. This abnormality is typified by offenders with high levels of callous/unemotional traits. A second subtype is characterized by hyper-reactions to personally relevant cues, interfering with executive functions that are otherwise needed to regulate behavior. This abnormality is prevalent in those with high externalizing characteristics. The investigators have developed cognitive skills training that addresses each of these specific deficits in distinct ways. These distinct interventions are intended to address mechanism-specific cognitive emotional dysfunction, as opposed to treating distinct dysfunctions with a uniform approach. The investigators' NIH-funded pilot work has shown evidence of improving outcomes in offenders by matching specific deficits with focused skills training. This project will execute a well-powered, randomized clinical trial to demonstrate reliability and generalizability of these effects. We expect to verify prior findings of improved outcomes by matching individual deficits with the targeted interventions. Effects of treatment on specific cognitive skills (assessed by laboratory-based tests) and real-world behavioral outcomes including substance use behaviors, institutional adjustment, and recidivism following release from prison will be examined. Further, advanced neuroimaging measures will be used to assess brain changes with treatment. This will aid in specifying potentially different mechanisms of treatment success in each respective group. This project addresses the ongoing need to improve and validate focused interventions that target specific deficits, replacing less-effective one-size-fits-all approaches.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
-
Participants with attention to context deficits will receive treatment either targeted towards their specific deficit (matched) or towards affective cognitive control deficits (mismatched).
Behavioral: Attention to Context (ATC) training · Behavioral: Affective Cognitive Control (ACC) training
Participants with affective cognitive control deficits will receive treatment either targeted towards their specific deficit (matched) or towards attention to context deficits (mismatched).
Behavioral: Attention to Context (ATC) training · Behavioral: Affective Cognitive Control (ACC) training
Participants in the no psychopathology group will receive one of the two treatment types (ATC or ACC).
Behavioral: Attention to Context (ATC) training · Behavioral: Affective Cognitive Control (ACC) training
ATC training focuses on learning to attend to and integrate contextual cues present in the environment. Three tasks, Reversal Learning, Divided Visual Field, and Affective Gaze, require ATC functioning and provide individuals with practice noticing changes in contextual information, such as rule changes and using emotion information to modulate behavior.
ACC training focuses on providing individuals with practice inhibiting behavior, particularly within motivational or affective contexts. Three tasks, Shapes, Numbers, and Lottery, tap ACC functioning and place demands on the basic employment of cognitive control, such as task switching, as well as on the concurrent engagement of cognitive control and affective processing.
Cognitive task performance - Stroop
Stroop task. Performance is quantified by number of correct responses (0 - 100)%.
Time frame: From enrollment to end of treatment at six weeks
Cognitive task performance - Lexical Decision Making
Lexical Decision Making task. Performance is quantified by number of correct responses (0 - 100%).
Time frame: From enrollment to end of treatment at six weeks
Cognitive task performance - Delay Discounting
Delay Discounting task. Performance is quantified quantified by calculating where the answers place the respondent amid reference discounting curves. Range 0.0-0.5.
Time frame: From enrollment to end of treatment at six weeks
Functional MRI - Go/NoGo task performance
Functional MRI task performance (Go/NoGo task). Performance is quantified by the number of 'false alarms' (responding to the NoGo stimulus). Range 0-39.
Time frame: Change assessed from enrollment to end of treatment at six weeks
Functional MRI - Go/Nogo brain response
Change (i.e. increased or decreased) in functional brain response (Blood Oxygen Level Dependent/BOLD) in region of interest (anterior cingulate) assessed using Statistical Parametric Mapping (SPM).
Time frame: Activity assessed during MRI scan. Change assessed from enrollment to end of treatment at six weeks
Real-World Outcomes - Substance use (TLFB)
Substance use. Assessed using the timeline follow back (TLFB) - calendar recording dates of use for stimulant drugs.
Time frame: From enrollment to six months post-release from incarceration
Real-World Outcomes - Substance use (ASE)
Substance use. Assessed using the Abstinence Self Efficacy scale (higher scores indicate greater difficulty with abstinence). Range 0-4.
Time frame: From enrollment to six months post-release from incarceration
Real-World Outcomes - Substance use (DUDIT)
Substance use. Assessed using the Drug Use Disorders Identification test (higher scores indicate more/severe substance use). Range 0-44.
Time frame: From enrollment to six months post-release from incarceration
Real-World Outcomes - Criminal behavior
Criminal behavior. Assessed using the Crime Inventory - records the number of instances of criminal behavior
Time frame: From enrollment to six months post-release from incarceration
Risky Impulsive Self-Destructive Behavior
The RISQ questionnaire measures risky, impulsive, and self-destructive behaviors in 8 domains (aggression, self-harm, gambling, impulsive spending/driving, impulsive eating, risky sex, illegal behavior, and alcohol use). For each behavior, respondents note the number of times they have engaged in the behavior in their lifetime. Higher scores indicate more severe risky, impulsive, and self destructive behavior.
Time frame: From enrollment to six months post-release from incarceration
Started Mar 2025 (actual). Primary completion is estimated for May 2029, 50 months after the start.
Of 25 interventional studies with no phase under Antisocial Personality Disorder, half reached primary completion within 53 months of starting (the median), counting those still running; a quarter within 29 and three quarters within 66. This study's planned 50 months is close to that.
How these figures are worked out, and which studies are left out of them.
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Antisocial Personality Disorder →
The Mind Research Network